NASDAQ: ENVB
Enveric Biosciences Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ENVB stock forecasts and price targets.

Forecast return on equity

Is ENVB forecast to generate an efficient return?

Company
-534.88%
Industry
130.77%
Market
-49.74%
ENVB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENVB forecast to generate an efficient return on assets?

Company
-329.33%
Industry
47.39%
ENVB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENVB earnings per share forecast

What is ENVB's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$12.90

ENVB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENVB$0.92N/AN/A
GTBP$0.83N/AN/A
SLRX$5.69N/AN/A
AZTR$0.80N/AN/A
INM$2.32N/AN/A

Enveric Biosciences Stock Forecast FAQ

What is ENVB's earnings growth forecast for 2025-2025?

(NASDAQ: ENVB) Enveric Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.23%.

Enveric Biosciences's earnings in 2025 is -$9,942,825.

In 2025, ENVB is forecast to generate -$41,877,064 in earnings, with the lowest earnings forecast at -$41,877,064 and the highest earnings forecast at -$41,877,064.

If you're new to stock investing, here's how to buy Enveric Biosciences stock.

What is ENVB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ENVB) forecast ROE is -534.88%, which is considered weak.

What is ENVB's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ENVB) Enveric Biosciences's current Earnings Per Share (EPS) is -$10.58. In 2025, ENVB's EPS is forecast to hit -$12.90 (min: -$12.90, max: -$12.90).

What is ENVB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ENVB) forecast ROA is -329.33%, which is lower than the forecast US Biotechnology industry average of 47.39%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.